查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2056590

生物反應器市場規模、佔有率、趨勢和預測：按類型、用途、規模、控制類型和地區分類，2026-2034年

Bioreactors Market Size, Share, Trends, and Forecast by Type, Usage, Scale, Control Type, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

2025年全球生物反應器市場規模為89億美元。展望未來，IMARC Group預測，該市場將以9.62%的複合年成長率從2026年成長至2034年，到2034年達到207億美元。目前，北美市場佔據主導地位，預計2025年市佔率將超過39.1%。生物反應器市場的成長主要受有效療法的日益普及和預防性疫苗需求不斷成長的驅動。

全球生物反應器市場正因生物製藥（包括單株抗體和疫苗）需求的成長而蓬勃發展。這主要得益於生物製藥生產技術的進步。此外，一次性生物反應器因其污染風險低、運作成本低而日益普及，進一步加速了市場成長。細胞和基因治療研究的快速發展以及人們對個人化醫療日益成長的興趣也推動了市場需求。此外，政府對生物製藥生產的支持以及有利於生物相似藥生產的法規也促進了市場擴張。同時，自動化和控制系統的技術進步提高了生物反應器的性能，滿足了生物技術和製藥行業的需求，從而刺激了市場發展。

美國作為主要市場脫穎而出，這主要得益於人們對生物相似藥生產日益成長的興趣。關鍵生物製藥專利到期以及替代藥物價格的不斷下降進一步推動了這一趨勢。此外，慢性病盛行率的上升也促進了對生物製藥的投資，並推動了對擴充性、高效生物反應器系統的需求。根據美國疾病管制與預防中心 (CDC) 2024 年的調查報告，美國有 1.29 億人患有至少一種美國衛生與公眾服務部定義的主要慢性病，包括心臟病、癌症、糖尿病、肥胖症和高血壓；42% 的人患有兩種或兩種以上慢性病；12% 的人患有至少五種慢性病。慢性病佔十大死因中的五項。過去 20 年來，慢性病的盛行率持續上升，預計未來將持續成長。此外，幹細胞研究和組織工程等生物製程應用的擴展也顯著增加了對專用生物反應器的需求。同時，學術機構與生技公司之間的合作正在加速生物製造技術的進步。此外，生物反應器在食品和農業生物技術領域日益重要的角色也為生物反應器市場帶來了光明的前景。

生物反應器市場趨勢：

一次性生物反應器的使用

一次性生物反應器（SUB）因其柔軟性、成本效益和降低污染風險等優勢而廣泛應用，這些優勢正在推動市場成長。據分析師稱，2023年全球一次性生物反應器市場規模達34億美元。展望未來，預計到2032年，該市場規模將達到111億美元，2024年至2032年的複合年成長率（CAGR）為13.8%。此外，與傳統的不銹鋼生物反應器不同，SUB採用一次性袋裝結構，無需在批次間進行徹底的清潔和滅菌。 2023年12月，Cellexus公司發布了氣升式拋棄式生物反應器系統，可提供最佳通氣，促進細胞快速生長。這種溫和的攪拌方式通常適用於微生物發酵和細胞培養。此外，領導企業正在開發創新的SUB設計，以滿足小規模研究到大規模生產的各種需求，進一步提升了生物反應器市場的前景。例如，2024年2月，合約研發生產機構（CDMO）藥明生物宣佈在愛爾蘭投資約3.4億美元，建造一座容量約54,000公升的一次性生物反應器生產設施。此外，2024年3月，賽默飛世爾科技（Thermo Fisher Scientific™）宣布對其HyPerforma™一次性生物反應器（SUB）產品平台進行一系列應用最佳化，以滿足強化補料分批培養、灌流培養和貼壁細胞培養的特定需求。同樣，2024年3月，Distek公司宣布推出一款用於哺乳動物細胞增殖和重組蛋白生產的一次性生物反應器（SUB）系統。此外，預計未來幾年，主要公司之間的持續合作將推動市場擴張。例如，2024年6月，Aragen Bioscience和Getinge宣布後者的一次性生產反應器（SUPR）已成功完成驗證。此次合作將 Getinge 的創新一次性技術與 Aragen 在生物製藥製造方面的專業知識相結合。

自動化技術的進步

生物反應器市場的關鍵趨勢之一是自動化技術的持續進步。新型控制系統和自動化技術的廣泛整合到生物反應器中，透過實現對pH值、溫度和溶解氧等關鍵參數的精確控制和即時監測，正在革新生物製程製程。這是市場成長的主要驅動力。例如，2023年8月，Repligen公司和Sartorius公司共同發布了一款整合式生物反應器系統，該系統由完全相容的嵌入式XCell ATF軟體和硬體模組組成。該系統提供預先定義的先進控制方案，並整合了製程分析技術（PAT）。根據Gartner預測，包括GenAI在內的AI主導自動化正在提高營運效率和靈活性，預計到2026年，30%的公司將實現超過一半網路活動的自動化，高於2023年的10%。這些進步正擴大應用於生物反應器，從而促進數據驅動的決策和製程最佳化。此外，該系統旨在為使用者提供一種高效控制細胞增殖和提高灌注過程中細胞保留率的方法，而無需單獨的細胞保留控制塔。另外，2023年9月，生物技術解決方案創新者Automated Control Concepts (ACC)發布了Lab Owl，這是一個先進的生物反應器控制和資料平台。該平台能夠調節和精確監控多個程式參數，從而獲得一致且可重複的結果。此外，2023年12月，Cultzyme推出了其生物反應器智慧操作奈米技術(BION)系統，該系統融合了人工智慧、硬體和雲端運算技術。該系統能夠控制生物製造過程，以最低的成本實現更有效率、更一致的結果。此外，對能夠實現從實驗室到生產規模無縫擴展並確保不同尺寸生物反應器性能一致的先進控制系統的需求不斷成長，也推動了生物反應器市場的擴張。例如，2024 年 4 月，Culture Biosciences 開發了一種具有先進控制系統和即時監控功能的生物反應器，專為中國倉鼠卵巢(CHO) 細胞設計。

開發永續生物程序

永續性正成為市場的重要考量。領先企業致力於最大限度地減少能源消耗和廢棄物產生，這推動了生物反應器市場的成長。 2023年10月，奈良先端科學技術大學院大學和藤田大學的研究團隊宣布推出一種混合型電腦/細胞內控制器（HISICC），該控制器將電腦控制的前饋控制與基因改造的活細胞無縫整合。這項技術有望生產出經濟高效且環境友善的化學品和燃料。此外，2023年11月，ADM和Solugen達成策略合作，共同開發可取代現有石化燃料衍生材料的分子，並建造一座佔地約50萬平方英尺的生物製造工廠，以拓展其低碳有機酸產品線。例如，英國已投資約1400萬美元用於21個跨領域合作研究項目，以促進永續生物製造，重點關注生物反應器創新和生物催化工藝，例如用於生產乙醯胺酚的可擴展連續流反應器。這些措施旨在提升生物技術製程的永續性，並支持英國在2050年實現淨零排放的目標。此外，生物反應器製造商正在投資於生物反應器設計的許多創新，例如更高效的攪拌和通氣系統，這提高了環保型生物製程解決方案的普及度。例如，勃林格殷格翰正在動物用藥品領域開發生物製程技術，並更加重視環境永續性。為此，該公司致力於最大限度地減少對環境的影響，從持續審查和評估現有實踐到最佳化抗原生技藥品的生產流程鏈。此外，英國研究與創新署（UKRI）於2024年3月宣布了21項跨產業合作，以促進英國永續生物製造的發展。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 二手資訊
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球生物反應器市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依類型

  • 一次使用
  • 多用途

第7章 市場區隔：依用途

  • 實驗室規模生產
  • 中試規模生產
  • 全面生產

第8章 市場區隔：依規模分類

  • 5L～20L
  • 20L～200L
  • 200L～1500L
  • 1500公升或以上

第9章 市場區隔：依控制類型分類

  • 手動的
  • 自動的

第10章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第11章 SWOT 分析

第12章：價值鏈分析

第13章：波特五力分析

第14章：價格分析

第15章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • 2mag AG
    • bbi-biotech GmbH
    • Bioengineering AG
    • Eppendorf SE
    • Getinge AB
    • Infors AG
    • Merck KGaA
    • Pall Corporation（Danaher Corporation）
    • Sartorius AG
    • Solaris Biotechnology Srl
    • Thermo Fisher Scientific Inc.
Product Code: SR112026A5500

The global bioreactors market size was valued at USD 8.9 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 20.7 Billion by 2034, exhibiting a CAGR of 9.62% during 2026-2034. North America currently dominates the market, holding a significant market share of over 39.1% in 2025. The increasing adoption of effective treatment drugs, along with the rising need for preventive vaccines, is primarily propelling the bioreactors market share.

The global bioreactors market is experiencing growth due to the rising demand for biologics, including monoclonal antibodies and vaccines. This can be attributed to the advancements in biopharmaceutical production. Along with this, the increasing adoption of single-use bioreactors, known for reduced contamination risks and operational costs, is further accelerating market growth. Rapid advancements in cell and gene therapy research, and growing interest in personalized medicine, are also propelling demand. Apart from this, government support for biologics manufacturing and favorable regulations for biosimilar production are contributing to the market's expansion. Moreover, technological improvements in automation and control systems are enhancing bioreactor performance, addressing the needs of the biotechnology and pharmaceutical industries, and fueling the market.

The United States stands out as a key market, driven by the growing focus on biosimilar production. This can be supported by the patent expirations of major biologics and the increasing affordability of these alternatives. In addition, the increasing prevalence of chronic diseases is encouraging biopharmaceutical investments, fueling the need for scalable and efficient bioreactor systems. As per 2024 research report by the CDC, in the United States, 129 million individuals have at least one major chronic disease defined by the US Department of Health and Human Services, such as heart disease, cancer, diabetes, obesity, or hypertension, with 42% having two or more and 12% having at least five. Chronic diseases account for five of the top 10 leading causes of death. Their prevalence has steadily increased over two decades and is expected to rise further. Besides this, expansion in bioprocessing applications, such as stem cell research and tissue engineering, is creating significant demand for specialized bioreactors. Concurrently, collaborations between academic institutions and biotech companies are accelerating advancements in biomanufacturing techniques. Furthermore, the increasing role of bioreactors in food and agricultural biotechnology is creating a positive bioreactors market outlook.

Bioreactors Market Trends:

Usage of Single-Use Bioreactors

Single-use bioreactors (SUBs) are gaining extensive popularity, owing to their benefits, such as flexibility, cost-effectiveness, reduced risk of contamination, etc. This, in turn, is stimulating the market. According to the analyst, the global single-use bioreactors market size reached USD 3.4 Billion in 2023. Looking forward, the market is projected to reach USD 11.1 Billion by 2032, thereby exhibiting a growth rate (CAGR) of 13.8% during 2024-2032. Moreover, unlike traditional stainless-steel bioreactors, SUBs adopt disposable bags, which aids in eliminating the need for extensive cleaning and sterilization between batches. In December 2023, Cellexus introduced airlift single-use disposable bioreactor systems that offer optimal aeration for the rapid growth of cells. This method of gentle agitation is usually suitable for microbial fermentation and cell culture. Besides this, key players are also producing innovative SUB designs, catering to both small-scale research and large-scale production needs, which is fueling the bioreactors market outlook. For instance, in February 2024, the contract development and manufacturing organization (CDMO), WuXi Biologics, announced the construction of a single-use site with approximately 54,000 L of disposable bioreactor capacity via an investment of roughly approximately USD 340 Million in Ireland. Additionally, in March 2024, Thermo Fisher Scientific(TM) launched a series of application-specific enhancements to the HyPerforma(TM) single-use bioreactor (SUB) product platform, each tailored to the unique requirements of intensified fed-batch, perfusion, and adherent cell cultures. Similarly, in March 2024, Distek, Inc. unveiled a single-use bioreactor (SUB) system for mammalian cell growth and recombinant protein production. Furthermore, continuous collaborations among prominent companies are projected to augment the market in the coming years. For example, in June 2024, Aragen Bioscience and Getinge announced the successful validation of the latter's single-use production reactors (SUPR). In line with this, the collaboration combined Getinge's innovative single-use technology and Aragen's expertise in biopharmaceutical manufacturing.

Advancements in Automation

On of the significant bioreactors market trends is continual advancements in automation. The widespread integration of novel control systems and automation with bioreactors is revolutionizing bioprocessing by enabling precise control over critical parameters, such as pH, temperature, dissolved oxygen, etc., and real-time monitoring. This is acting as a significant growth-inducing factor. For instance, in August 2023, Repligen Corporation and Sartorius introduced an integrated bioreactor system that comprises a fully compatible embedded XCell ATF software and hardware module offering predefined advanced control recipes with integrated process analytical technology (PAT). According to Gartner, by 2026, 30% of enterprises will automate over half of network activities, up from 10% in 2023, as AI-driven automation, including GenAI, boosts operational efficiency and agility. These advancements are increasingly applied in bioreactors, enhancing data-driven decision-making and process optimization. Additionally, the system aims to provide users with a streamlined way to control cell growth and enhance cell retention in perfusion processes without utilizing a separate cell retention control tower. Besides this, in September 2023, Automated Control Concepts (ACC), one of the innovators in biotechnology solutions, released its cutting-edge bioreactor control and data platform, Lab Owl, that allows for adjustment of multiple process parameters and precise monitoring, resulting in consistent and reproducible outcomes. Apart from this, in December 2023, Cultzyme launched a bioreactor intelligent operative nanotechnology (BION) system equipped with AI, hardware, and cloud computing to control the biomanufacturing process and achieve consistent outcomes more efficiently and at minimal costs. Furthermore, the escalating demand for advanced control systems, as they facilitate seamless scale-up from laboratory to production scale, which aids in ensuring consistent performance across numerous bioreactor sizes, is also increasing the bioreactors market revenue. For instance, in April 2024, Culture Biosciences created bioreactors with advanced control systems and real-time monitoring capabilities designed to accommodate Chinese Hamster Ovary (CHO) cells.

Development of Sustainable Bioprocessing

Sustainability is becoming a critical consideration in the market. Prominent players are focusing on minimizing energy consumption and waste generation, which is stimulating the bioreactors market growth. In October 2023, a team of researchers at the Nara Institute of Science and Technology and Fujita University introduced a hybrid in silico/in-cell controller (HISICC) that seamlessly integrates computerized feedforward control with genetically modified living cells, offering the potential for cost-effective and eco-friendly chemical and fuel production. Besides this, in November 2023, ADM and Solugen formed a strategic partnership to build an approximately 500,000-ft2 biomanufacturing facility to develop molecules to replace existing fossil fuel-based materials and scale its line of lower-carbon organic acids. For instance, the UK has invested approximately USD 14 Million in 21 cross-sector collaborations to advance sustainable biomanufacturing, focusing on bioreactor innovations and biocatalytic processes, such as scalable continuous flow reactors for paracetamol production. These initiatives aim to enhance the sustainability profile of biotechnology processes and support the UK's goal of achieving Net Zero by 2050. Moreover, bioreactor manufacturers are investing in several innovations in bioreactor design, such as more efficient mixing and aeration systems, which is elevating the popularity of greener bioprocessing solutions. For example, Boehringer Ingelheim offers bioprocess technology operations in animal health with an improved focus on environmental sustainability. In line with this, from continuously discussing and evaluating current practices to optimizing process chains for antigenic biological manufacturing, the company is strongly committed to minimizing its environmental footprint. Additionally, in March 2024, the UK Research and Innovation (UKRI) announced 21 cross-sector collaborations to drive advancements in sustainable biomanufacturing across the country.

Bioreactors Industry Segmentation:

This report provides an analysis of the key trends in each segment of the global bioreactors market, along with forecast at the global, regional, and country levels from 2026-2034. The market has been categorized based on type, usage, scale, control type, and region.

Analysis by Type:

  • Single-Use
  • Multi-Use

Multi-use stands as the largest component in 2025, holding around 65.9% of the market. Multi-use bioreactors are the most versatile, cost-effective, and efficient bioreactors for diverse bioproduction processes. They are used in a wide range of pharmaceutical, biotechnology, and research applications because they can accommodate various cell culture and fermentation processes. Their design is robust, reusable, and scalable, making them ideal for large-scale manufacturing and experimental applications. Multi-use bioreactors are in line with the industry's demand for high-quality production and sustainable practices, as they reduce operational costs and ensure consistent performance. Their adaptability to advanced technologies further reinforces their position as the largest and most impactful segment in the bioreactors market.

Analysis by Usage:

  • Lab-Scale Production
  • Pilot-Scale Production
  • Full-Scale Production

Pilot-scale production leads the market with around 49.1% of market share in 2025. Pilot-scale production in bioreactors serves as a crucial intermediary step between laboratory research and full-scale manufacturing in the biopharmaceutical industry. This phase allows for the optimization of bioprocesses on a scale that closely mimics commercial production, providing valuable insights into process performance, scalability, and reproducibility. Pilot-scale bioreactors typically range from 50 to 500 liters in capacity. For instance, in January 2024, San Francisco-based SciFi Foods announced the successful completion of its first commercial bioreactor facility in San Leandro, California. They are used to test and refine production parameters such as cell growth, nutrient consumption, and product yield under conditions that replicate those of large-scale operations. Additionally, pilot-scale production facilitates regulatory compliance by generating data required for process validation and quality assurance. Companies like GE Healthcare and Sartorius offer advanced pilot-scale bioreactor systems equipped with sophisticated monitoring and control technologies, enabling precise control over critical process parameters and ensuring a seamless transition to large-scale manufacturing.

Analysis by Scale:

  • 5L-20L
  • 20L-200L
  • 200L-1500L
  • Above 1500L

200L-1500L leads the market with around 47.8% of market share in 2025. Bioreactors are designed in various scales to meet the needs of different stages of bioprocessing, from research and development to full-scale commercial production. Bioreactors in the 200L to 1500L range are used for pilot-scale production, providing a realistic simulation of commercial-scale operations and facilitating the validation of production processes. These bioreactors hold significant prominence in the biopharmaceutical sector due to their versatility and scalability. These systems bridge the gap between laboratory-scale research and large-scale manufacturing, enabling efficient process optimization and technology transfer. Their adoption is driven by the rising demand for biologics, including monoclonal antibodies and vaccines, which require consistent and reproducible production environments.

Analysis by Control Type:

  • Manual
  • Automated

Automated leads the market with around 65.9% of market share in 2025. Automated bioreactors are revolutionizing bioprocessing by integrating advanced control systems that enhance precision, efficiency, and scalability. They allow for real-time monitoring and control of critical parameters, including temperature, pH, dissolved oxygen, etc. The system's automation capabilities minimize human intervention, thereby reducing the risk of contamination and errors while optimizing cell growth and product yield. For example, in May 2024, a team of researchers at Florida International University developed an automated 3D-printed bioreactor to grow bone in the lab. Additionally, biopharmaceutical manufacturers offer versatile and robust solutions to enhance productivity and maintain high standards of quality and compliance. For instance, in September 2023, Automated Control Concepts (ACC), one of the leading innovators in biotechnology solutions, announced the development of its cutting-edge bioreactor control and data platform, Lab Owl, to redefine the landscape of bioprocessing.

Regional Analysis:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

In 2025, North America accounted for the largest market share of over 39.1%. The North America bioreactors market is witnessing robust growth, fueled by the region's strong emphasis on biopharmaceutical research, development, and manufacturing. Additionally, advancements in bioprocessing technologies, such as single-use bioreactors and automation, are enhancing the efficiency and scalability of biomanufacturing processes. The presence of major pharmaceutical and biotechnology companies, coupled with supportive government initiatives and funding, is further propelling the bioreactors market demand. In February 2024, Thermo Fisher Scientific expanded its manufacturing capacity at its Missouri, U.S. site to produce complex biologic treatments for a range of diseases, including cancer, autoimmune conditions, and rare disorders. Furthermore, the North America bioreactors market is poised for continued growth, driven by technological advancements and increasing biopharmaceutical production demands. For instance, in March 2023, Micro Digital Co. signed a formal contract to supply bioreactors to expand its presence in North America.

Key Regional Takeaways:

United States Bioreactors Market Analysis

In 2025, US accounted for around 87.6% of the total North America bioreactors market. The United States is at the forefront of adopting bioreactor technology, significantly advancing its position in biotechnology and pharmaceutical manufacturing. Bioreactors are streamlining the production of biologics, including vaccines, monoclonal antibodies, and regenerative medicine solutions, addressing both domestic and global healthcare needs. Key advantages include higher production efficiency, scalability, and enhanced process control, enabling faster responses to medical demands. Innovations such as single-use bioreactors are reducing costs and contamination risks while supporting sustainability goals. For instance, The United States, as the world's third-largest importer of bioreactors with 191 shipments, primarily sources from Mexico, India, and Canada. This strategic importation supports advancements in biotechnology and pharmaceuticals, bolstering the nation's innovation and economic growth. Major states like California, Massachusetts, and North Carolina, with robust biotechnology clusters, are hubs for bioreactor deployment, fostering collaborations and driving R&D. These advancements are further strengthening the U.S. position as a leader in life sciences, with companies and research centers contributing to breakthroughs in personalized medicine and cell-based therapies. Bioreactors are transforming industries beyond healthcare, including biofuels and agriculture, enhancing resource management and sustainability efforts across diverse sectors.

Asia Pacific Bioreactors Market Analysis

The Asia-Pacific region is emerging as a significant hub for bioreactor adoption, driven by advancements in biotechnology and the region's focus on pharmaceutical and biopharmaceutical development. Countries such as China, India, Japan, and South Korea are leveraging bioreactor technologies to enhance vaccine production, biologics manufacturing, and regenerative medicine. These innovations are enabling cost-effective and scalable production processes, crucial for meeting the demands of growing healthcare markets. For instance, India imported 2,480 bioreactor shipments from March 2023 to February 2024, primarily from the United States, Switzerland, and Germany. This significant import activity underscores India's commitment to advancing its biotechnology sector, enhancing research capabilities, and fostering economic growth. The region's favorable regulatory frameworks and substantial investments in research hubs, particularly in cities like Shanghai, Hyderabad, and Tokyo, are positioning Asia-Pacific as a leader in bioprocessing. The adoption of single-use bioreactors in South Korea's biopharmaceutical industry and China's focus on monoclonal antibody production exemplify the region's dynamic advancements. With strategic location advantages, including proximity to raw materials and skilled labor, Asia-Pacific is fostering sustainable biotechnology growth, meeting global supply demands, and addressing critical healthcare challenges.

Europe Bioreactors Market Analysis

The adoption of bioreactors in Europe is significantly transforming industries like pharmaceuticals and biotechnology by advancing production efficiency and sustainability. Bioreactors enable precise environmental control, enhancing the yield of biologics and biofuels while reducing waste and resource consumption. Europe, particularly Germany and Switzerland, leads in bioreactor innovation, leveraging advancements in automation and sensor technologies to optimize processes. Germany's pharmaceutical hubs utilize bioreactors to streamline vaccine production, meeting global health demands rapidly. Similarly, Switzerland's biotechnology sector has integrated bioreactors to enhance monoclonal antibody manufacturing, positioning the country as a leader in therapeutic advancements. Switzerland's export of bioreactors and effluent treatment equipment significantly benefits Europe by enhancing wastewater management and environmental sustainability. In 2024, Switzerland exported 2,474 shipments of MBR bioreactor treatment plant sections and related equipment, indicating robust trade activity in this sector. The widespread adoption across European countries, including the Netherlands and France, emphasizes the region's commitment to green technology and reduced carbon footprints. By fostering innovation hubs and research centers, Europe strengthens its position in global biotechnology, offering scalable solutions that address industrial and environmental challenges while maintaining a competitive edge in life sciences.

Latin America Bioreactors Market Analysis

The adoption of bioreactors in Latin America is revolutionizing biotechnology and sustainable production. Advancements in scalable cell culture and fermentation technologies enable efficient vaccine development and bio-based manufacturing. Countries like Brazil are leveraging bioreactors for ethanol production from sugarcane, enhancing renewable energy output. Similarly, Mexico utilizes bioreactors in pharmaceutical innovation, improving drug manufacturing. According to reports, The Mexico small-scale bioreactors market is projected to grow from USD 36.9 Million in 2018 to USD 154.1 Million by 2032, driven by increasing adoption in medical, food, agriculture, and energy sectors. These innovations position Latin America as a global hub for biotechnological progress. Strategically located near global trade routes, the region fosters economic growth through exports. States such as Sao Paulo and Jalisco exemplify leadership, driving technological adoption to support environmental sustainability and economic development.

Middle East and Africa Bioreactors Market Analysis

The Middle East and Africa are rapidly embracing bioreactors, revolutionizing biotechnology, and healthcare sectors. Bioreactors offer advantages such as enhanced cell growth, scalability, and precise environmental control, fostering innovation in pharmaceutical production and wastewater treatment. According to reports, the United Arab Emirates imported 12 bioreactor shipments, ranking 22nd globally. India led with 2,480 shipments, followed by Vietnam with 225, and the United States with 209. Advancements in single-use bioreactors and automation have streamlined operations, making them accessible to emerging markets. For instance, Saudi Arabia is utilizing bioreactors for vaccine manufacturing, ensuring local supply chains, while South Africa is employing them in biofuel production to address energy sustainability. Strategic positioning in these regions promotes economic diversification and self-reliance, making bioreactors a pivotal tool for regional growth.

Competitive Landscape:

The bioreactors market forecast indicates strong competition in the market, as key players iare focusing on innovation to enhance efficiency and scalability in bioprocessing. They are investing in advanced technologies such as single-use systems to meet the growing demand for flexible and cost-effective solutions. Companies are also expanding their portfolios to include modular and custom bioreactors tailored to specific applications such as cell and gene therapy. Along with this, partnerships with biotech firms and research institutions are strengthening R&D efforts, fostering the development of next-generation bioreactors. Additionally, manufacturers are leveraging automation and digital monitoring tools to improve process control and product quality.

The report provides a comprehensive analysis of the competitive landscape in the bioreactors market with detailed profiles of all major companies, including:

  • 2mag AG
  • bbi-biotech GmbH
  • Bioengineering AG
  • Eppendorf SE
  • Getinge AB
  • Infors AG
  • Merck KGaA
  • Pall Corporation (Danaher Corporation)
  • Sartorius AG
  • Solaris Biotechnology Srl
  • Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

1. How big is the bioreactors market?

2. What is the future outlook of the bioreactors market?

3. What are the key factors driving the bioreactors market?

4. Which region accounts for the largest bioreactors market share?

5. Which are the leading companies in the global bioreactors market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Bioreactors Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Single-Use
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Multi-Use
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Usage

  • 7.1 Lab-Scale Production
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Pilot-Scale Production
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Full-Scale Production
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Scale

  • 8.1 5L-20L
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 20L-200L
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 200L-1500L
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Above 1500L
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Control Type

  • 9.1 Manual
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Automated
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 2mag AG
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 bbi-biotech GmbH
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Bioengineering AG
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Eppendorf SE
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Getinge AB
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Infors AG
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Merck KGaA
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Pall Corporation (Danaher Corporation)
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 Sartorius AG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Solaris Biotechnology Srl
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Thermo Fisher Scientific Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Bioreactors Market: Major Drivers and Challenges
  • Figure 2: Global: Bioreactors Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Bioreactors Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Bioreactors Market: Breakup by Type (in %), 2025
  • Figure 5: Global: Bioreactors Market: Breakup by Usage (in %), 2025
  • Figure 6: Global: Bioreactors Market: Breakup by Scale (in %), 2025
  • Figure 7: Global: Bioreactors Market: Breakup by Control Type (in %), 2025
  • Figure 8: Global: Bioreactors Market: Breakup by Region (in %), 2025
  • Figure 9: Global: Bioreactors (Single-Use) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Bioreactors (Single-Use) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Bioreactors (Multi-Use) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Bioreactors (Multi-Use) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Bioreactors (Lab-Scale Production) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Bioreactors (Lab-Scale Production) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Bioreactors (Pilot-Scale Production) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Bioreactors (Pilot-Scale Production) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Bioreactors (Full-Scale Production) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Bioreactors (Full-Scale Production) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Bioreactors (5L-20L) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Bioreactors (5L-20L) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Bioreactors (20L-200L) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Bioreactors (20L-200L) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Bioreactors (200L-1500L) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Bioreactors (200L-1500L) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Bioreactors (Above 1500L) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Bioreactors (Above 1500L) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Bioreactors (Manual) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Bioreactors (Manual) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Bioreactors (Automated) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Bioreactors (Automated) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: North America: Bioreactors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: North America: Bioreactors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: United States: Bioreactors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: United States: Bioreactors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Canada: Bioreactors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Canada: Bioreactors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Asia-Pacific: Bioreactors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Asia-Pacific: Bioreactors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: China: Bioreactors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: China: Bioreactors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Japan: Bioreactors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Japan: Bioreactors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: India: Bioreactors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: India: Bioreactors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: South Korea: Bioreactors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: South Korea: Bioreactors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Australia: Bioreactors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Australia: Bioreactors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Indonesia: Bioreactors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Indonesia: Bioreactors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Others: Bioreactors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Others: Bioreactors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Europe: Bioreactors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Europe: Bioreactors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Germany: Bioreactors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Germany: Bioreactors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: France: Bioreactors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: France: Bioreactors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: United Kingdom: Bioreactors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: United Kingdom: Bioreactors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Italy: Bioreactors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Italy: Bioreactors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Spain: Bioreactors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Spain: Bioreactors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Russia: Bioreactors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Russia: Bioreactors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Others: Bioreactors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Others: Bioreactors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Latin America: Bioreactors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Latin America: Bioreactors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Brazil: Bioreactors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Brazil: Bioreactors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Mexico: Bioreactors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Mexico: Bioreactors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Others: Bioreactors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Others: Bioreactors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Middle East and Africa: Bioreactors Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: Middle East and Africa: Bioreactors Market: Breakup by Country (in %), 2025
  • Figure 79: Middle East and Africa: Bioreactors Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 80: Global: Bioreactors Industry: SWOT Analysis
  • Figure 81: Global: Bioreactors Industry: Value Chain Analysis
  • Figure 82: Global: Bioreactors Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Bioreactors Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Bioreactors Market Forecast: Breakup by Type (in Million USD), 2026-2034
  • Table 3: Global: Bioreactors Market Forecast: Breakup by Usage (in Million USD), 2026-2034
  • Table 4: Global: Bioreactors Market Forecast: Breakup by Scale (in Million USD), 2026-2034
  • Table 5: Global: Bioreactors Market Forecast: Breakup by Control Type (in Million USD), 2026-2034
  • Table 6: Global: Bioreactors Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Bioreactors Market: Competitive Structure
  • Table 8: Global: Bioreactors Market: Key Players